• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含有BCR寡聚化结构域(氨基酸1 - 160)的肽可逆转p210bcr-abl阳性32D髓系白血病细胞的转化表型。

Peptide containing the BCR oligomerization domain (AA 1-160) reverses the transformed phenotype of p210bcr-abl positive 32D myeloid leukemia cells.

作者信息

Guo X Y, Cuillerot J M, Wang T, Wu Y, Arlinghaus R, Claxton D, Bachier C, Greenberger J, Colombowala I, Deisseroth A B

机构信息

Department of Internal Medicine and the Gene Therapy Program of the Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut 06520-8032, USA.

出版信息

Oncogene. 1998 Aug 20;17(7):825-33. doi: 10.1038/sj.onc.1201999.

DOI:10.1038/sj.onc.1201999
PMID:9779999
Abstract

We first showed that the introduction of a bcr-abl transcription unit into the 32D murine myeloid cell line (P210bcrabl32D) converts this cell line from an IL3 dependent cell line to an IL3 growth independent cell line. We next cloned a fragment of the bcr-abl cDNA, which codes for the bcr oligomerization domain and neighboring regions. To test for a transformation inhibitory effect of this oligomerization inhibitory peptide transcription unit on the p210bcr-abl mediated IL3 independent growth of the P210bcrabl32D cell line, we transiently co-electroporated into the growth factor dependent 32D cells, mixtures of plasmids which contained varying ratios of the plasmid expression vectors for the bcr oligomerization inhibitory peptide along with a smaller amount of the plasmid expression vector for the full length p210bcr-abl. (The P210bcr-abl protein converts the 32D from a growth factor dependent into a growth factor independent cell line.) We then showed that the oligomerization domain containing fragment from the bcr and bcr-abl proteins, can be used to inhibit the IL3 independent growth of p210bcr-abl positive 32D cells. These studies may be of eventual interest for those investigators whose goal is to design molecular therapeutic approaches to CML based on the use of peptidomimetic chemical functionalities, which mimic the structure and the inhibitory binding properties of the oligomerization domain containing fragment so as to inhibit the transforming function of the P210bcr-abl oncoprotein.

摘要

我们首先证明,将bcr-abl转录单位引入32D小鼠髓系细胞系(P210bcrabl32D)可使该细胞系从依赖白细胞介素3(IL3)的细胞系转变为不依赖IL3生长的细胞系。接下来,我们克隆了一段bcr-abl cDNA片段,该片段编码bcr寡聚化结构域及相邻区域。为了测试这种寡聚化抑制肽转录单位对P210bcrabl32D细胞系中p210bcr-abl介导的不依赖IL3生长的转化抑制作用,我们将含有不同比例bcr寡聚化抑制肽质粒表达载体以及少量全长p210bcr-abl质粒表达载体的质粒混合物,瞬时共电穿孔导入依赖生长因子的32D细胞中。(P210bcr-abl蛋白可使32D细胞从依赖生长因子转变为不依赖生长因子的细胞系。)然后我们证明,来自bcr和bcr-abl蛋白的含寡聚化结构域片段可用于抑制p210bcr-abl阳性32D细胞的不依赖IL3生长。对于那些旨在基于使用拟肽化学官能团设计慢性粒细胞白血病分子治疗方法的研究人员来说,这些研究最终可能会引起他们的兴趣,这些拟肽化学官能团模仿含寡聚化结构域片段的结构和抑制性结合特性,从而抑制P210bcr-abl癌蛋白的转化功能。

相似文献

1
Peptide containing the BCR oligomerization domain (AA 1-160) reverses the transformed phenotype of p210bcr-abl positive 32D myeloid leukemia cells.含有BCR寡聚化结构域(氨基酸1 - 160)的肽可逆转p210bcr-abl阳性32D髓系白血病细胞的转化表型。
Oncogene. 1998 Aug 20;17(7):825-33. doi: 10.1038/sj.onc.1201999.
2
Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein.BCR-ABL癌蛋白导致的粘着斑激酶(p125FAK)的酪氨酸磷酸化及激活
Exp Hematol. 1995 Oct;23(11):1153-9.
3
Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation.Bcr、Abl和Bcr-Abl蛋白在正常细胞和白血病细胞中的亚细胞定位以及表达与髓系分化的相关性。
J Clin Invest. 1993 Oct;92(4):1925-39. doi: 10.1172/JCI116786.
4
Activation of Src kinases p53/56lyn and p59hck by p210bcr/abl in myeloid cells.p210bcr/abl在髓系细胞中对Src激酶p53/56lyn和p59hck的激活作用。
Cancer Res. 1996 Aug 1;56(15):3589-96.
5
The presence of the Rb c-box peptide in the cytoplasm inhibits p210bcr-abl transforming function.细胞质中Rb c盒肽的存在会抑制p210bcr-abl的转化功能。
Oncogene. 1999 Feb 25;18(8):1589-95. doi: 10.1038/sj.onc.1202479.
6
Expression of the chronic myelogenous leukemia-associated p210bcr/abl oncoprotein in a murine IL-3 dependent myeloid cell line.慢性粒细胞白血病相关的p210bcr/abl癌蛋白在小鼠白细胞介素-3依赖的髓系细胞系中的表达。
Oncogene. 1991 Feb;6(2):275-82.
7
Intrinsic regulation of the interactions between the SH3 domain of p85 subunit of phosphatidylinositol-3 kinase and the protein network of BCR/ABL oncogenic tyrosine kinase.磷脂酰肌醇-3激酶p85亚基的SH3结构域与BCR/ABL致癌性酪氨酸激酶蛋白网络之间相互作用的内在调节
Exp Hematol. 2005 Oct;33(10):1222-8. doi: 10.1016/j.exphem.2005.06.030.
8
Clonal evolution in a myeloid cell line transformed to interleukin-3 independent growth by retroviral transduction and expression of p210bcr/abl.通过逆转录病毒转导和p210bcr/abl表达转化为白介素-3非依赖生长的髓系细胞系中的克隆进化。
Blood. 1992 Oct 1;80(7):1788-97.
9
Bcr: a negative regulator of the Bcr-Abl oncoprotein.Bcr:Bcr-Abl癌蛋白的负调控因子。
Oncogene. 1999 Aug 5;18(31):4416-24. doi: 10.1038/sj.onc.1202828.
10
p210BCR/ABL, p190BCR/ABL, and TEL/ABL activate similar signal transduction pathways in hematopoietic cell lines.p210BCR/ABL、p190BCR/ABL和TEL/ABL在造血细胞系中激活相似的信号转导途径。
Oncogene. 1996 Sep 19;13(6):1147-52.

引用本文的文献

1
Extracellular Vesicles and Immunity: At the Crossroads of Cell Communication.细胞外囊泡与免疫:细胞通讯的十字路口
Int J Mol Sci. 2024 Jan 18;25(2):1205. doi: 10.3390/ijms25021205.
2
Monomerization of ALK Fusion Proteins as a Therapeutic Strategy in -Rearranged Non-small Cell Lung Cancers.ALK融合蛋白单体化作为间变性大细胞淋巴瘤相关非小细胞肺癌的一种治疗策略
Front Oncol. 2020 Apr 2;10:419. doi: 10.3389/fonc.2020.00419. eCollection 2020.
3
BCR: a new target in resistance mediated by BCR/ABL-315I?BCR:由BCR/ABL-315I介导的耐药中的新靶点?
Genes Cancer. 2016 Jan;7(1-2):36-46. doi: 10.18632/genesandcancer.93.
4
Structure and dynamic regulation of Abl kinases.Abl 激酶的结构与动态调节。
J Biol Chem. 2013 Feb 22;288(8):5443-50. doi: 10.1074/jbc.R112.438382. Epub 2013 Jan 11.
5
Improved coiled-coil design enhances interaction with Bcr-Abl and induces apoptosis.改良的螺旋-螺旋结构增强了与 Bcr-Abl 的相互作用并诱导细胞凋亡。
Mol Pharm. 2012 Jan 1;9(1):187-95. doi: 10.1021/mp200461s. Epub 2011 Dec 12.
6
Disruption of Bcr-Abl coiled coil oligomerization by design.设计破坏 Bcr-Abl 卷曲螺旋寡聚体。
J Biol Chem. 2011 Aug 5;286(31):27751-60. doi: 10.1074/jbc.M111.264903. Epub 2011 Jun 9.
7
The nuclear translocation assay for intracellular protein-protein interactions and its application to the Bcr coiled-coil domain.核转位检测法用于检测细胞内蛋白-蛋白相互作用及其在 Bcr 卷曲螺旋结构域中的应用。
Biotechniques. 2010 Jul;49(1):519-24. doi: 10.2144/000113452.
8
Genomic and functional assays demonstrate reduced gammaretroviral vector genotoxicity associated with use of the cHS4 chromatin insulator.基因组和功能分析表明,与使用cHS4染色质绝缘子相关的γ逆转录病毒载体基因毒性降低。
Mol Ther. 2009 Apr;17(4):716-24. doi: 10.1038/mt.2009.7. Epub 2009 Feb 24.
9
Bcr is a negative regulator of the Wnt signalling pathway.Bcr是Wnt信号通路的负调节因子。
EMBO Rep. 2005 Nov;6(11):1095-100. doi: 10.1038/sj.embor.7400536. Epub 2005 Oct 7.
10
Tyrosine kinase inhibitors targeted to the epidermal growth factor receptor subfamily: role as anticancer agents.靶向表皮生长因子受体亚家族的酪氨酸激酶抑制剂:作为抗癌药物的作用。
Drugs. 2000 Apr;59(4):753-67. doi: 10.2165/00003495-200059040-00003.